Clarus Therapeutics Announces Comprehensive Settlement of Patent Litigation With Lipocine
Go back to Clarus Therapeutics Announces Comprehensive Settlement of Patent Litigation With Lipocine| LIPOCINE (NASDAQ: LPCN) | Delayed: 2.36 +0.06 (2.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.30 | 52 Week High | $14.80 | |||
| Open | $2.22 | 52 Week Low | $2.51 | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $-0.69 | |||
| Volume | 35,051 | |||||

